文献速递主动脉疾病

晚期EVAR失败的微创开放转换治疗

Minimally Invasive Open Conversion for Late EVAR Failure.
PubMed 文献 · Ann Vasc Surg · 2019-10-15

该回顾性研究纳入2014年5月至2018年6月在本机构接受微创开放转换(MOC)的连续10例EVAR失败患者,指征为内漏伴囊体增长至少>5 mm且既往腔内封堵失败。30天无死亡或再干预,主要并发症率10%;平均随访22.9±15.9个月无再干预,死亡率20%。MOC可能是EVAR失败的安全手术方案。

要点

  • MOC适用于内漏伴囊体增长>5 mm且腔内封堵失败者。
  • 小切口、肾下阻断、部分移除内移植物是MOC技术要点。
  • 30天无死亡或再干预,主要并发症率10%。

核心结论

  • 尽管开放转换潜在风险高,MOC似乎是EVAR失败的安全手术方案。

研究设计与样本

  • 回顾性研究,基于前瞻性录入的计算机数据库,纳入2014年5月至2018年6月连续10例接受MOC的患者。

主要发现

  • MOC距EVAR平均间隔45.1个月(范围14-128)。
  • 30天无死亡或再干预,主要并发症率10%(1例术后肺炎)。
  • 平均随访22.9±15.9个月无再干预,死亡率20%,其中动脉瘤相关死亡1例(10%)为MOC后32个月移植物感染,心脏事件1例(10%)在18个月。

关键数值与推荐

  • MOC指征:内漏伴囊体增长至少>5 mm(近6个月内)且既往腔内封堵尝试失败。
  • MOC指征构成:Ia型内漏3例(30%),持续性II型内漏4例(40%),III型内漏1例(10%),不确定或V型内漏2例(20%)。

临床怎么用

  • 对于EVAR后晚期失败且腔内封堵失败的患者,可考虑采用小切口、肾下阻断、部分移除内移植物的MOC技术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: With the increasing use of endovascular aortic aneurysm repair (EVAR), open repair after aortic stent grafting is of growing interest. The surgical conversion treatment may be a very challenging process with high mortality and in-hospital complication rates. The aim of this article is to present our experience in patients with EVAR failure treated by minimally invasive open conversion (MOC) and its technical aspects. METHODS: A retrospective study was conducted on a prospectively compiled computerized database of consecutive patients treated by MOC at our institution between May 2014 and June 2018. Indications for treatment were endoleaks with sac growth at least >5 mm in the last 6 months and failure of previous endovascular tentative for aneurysm sealing. Demographics of the patients, reason for conversion, previous endovascular procedures, surgical outcomes, and survival were reviewed. MOC was performed by a small abdominal incision, infrarenal clamping, and partial explantation of the endograft in all patients. RESULTS: A total of 10 patients were treated during the study period. The mean interval to MOC after EVAR was 45.1 months (range, 14-128). Indications for MOC included type Ia endoleak in three patients (30%), persistent type II EL in four (40%), and type III EL in one patient (10%), indeterminate or type V EL in two (20%). At 30 days, no deaths or reinterventions were reported, and major complication rate was 10% (one postoperative pneumonia). At mean follow-up of 22.9 ± 15.9 months, no reinterventions were described. Death rate was (20%) with one aneurysm-related death (10%) for graft infection 32 months after MOC and one (10%) cardiac event at 18 months. CONCLUSIONS: Despite the potential high risk of open conversion, MOC appears to be a safe surgical solution for EVAR failure. This potentially challenging operation may be improved with minimally invasive techniques that are presented.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Stilo F, Montelione N, Catanese V, et al. Minimally Invasive Open Conversion for Late EVAR Failure. Ann Vasc Surg. 2019. PMID: 31626941. doi:10.1016/j.avsg.2019.08.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。